Search

Now showing items 1-10 of 25

Menopausal symptoms as predictors of long-term adherence in the International breast cancer intervention study (IBIS-1)

Smith, SG; Sestak, I; Forbes, J; Howell, A; Cuzick, JJ (2017-02)

Long-term comparison of anastrozole versus tamoxifen: Results from LATTE/ATAC

Cuzick, J; Sestak, I; Bianco, A; Strobbe, L; Bergh, J; Hanusch, C; Neven, P; Dowsett, M; Forbes, JF; Buzdar, A;... (2017-02)

Comprehensive comparison of prognostic signatures for breast cancer in TransATAC

Sestak, I; Buus, R; Cuzick, J; Dubsky, P; Kronenwett, R; Ferree, S; Sgroi, D; Schnabel, C; Baehner, R; Mallon, E;... (2017-02)

Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M;... (2015-08)

Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer

Dowsett, M; Sestak, I; Buus, R; Lopez-Knowles, E; Mallon, E; Howell, A; Forbes, JF; Buzdar, A; Cuzick, J (2015-06-15)

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Mote, PA; Gompel, A; Howe, C; Hilton, HN; Sestak, I; Cuzick, J; Dowsett, M; Hugol, D; Forgez, P; Byth, K;... (2015-06)

Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials

Brentnall, AR; Cuzick, J; Byers, H; Segal, C; Reuter, C; Detre, S; Sestak, I; Howell, A; Powles, TJ; Newman, WG;... (2016-08)

Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors

Sestak, I; Dowsett, M; Ferree, S; Baehner, FL; Cuzick, J (2016-08)

Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy

Buus, R; Sestak, I; Kronenwett, R; Denkert, C; Dubsky, P; Krappmann, K; Scheer, M; Petry, C; Cuzick, J; Dowsett, M (2016-11)

Update on breast cancer risk prediction and prevention

Sestak, I; Cuzick, J (2015-02)

1
2
3